GSK Plays Down Seretide/Advair Generic Launch In U.K., But Pressure Builds

Mylan’s launch in the U.K. of the first generic version of anti-asthma drug Seretide (Advair in the U.S.) has been a long-time coming -- and the copycat version has key differences from the original -- but the event underscores building pressures on GSK’s respiratory franchise.